BioMarin (BMRN) Says Data from Phase 1/2 '190 Study Shows Stabilization of Disease
Go back to BioMarin (BMRN) Says Data from Phase 1/2 '190 Study Shows Stabilization of Disease| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 91.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.20 | 52 Week High | $108.96 | |||
| Open | $91.20 | 52 Week Low | $62.12 | |||
| Day High | $91.20 | P/E | N/A | |||
| Day Low | $91.20 | EPS | $-1.27 | |||
| Volume | 29 | |||||
